CD38 and neoplasm: While a single treatment of an anti-PD-L1 antibody showed no anti-tumor effects, sEVs loaded with CD38-targeting siRNA suppressed tumor growth and induced M1 macrophage polarization in tumor tissue of an HCC mouse model [85].